Persistence Market Research Company
Enquire Now Report Sample

Prostate Cancer Hormone Therapy Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Prostate Cancer Hormone Therapy Market Drug Class (Androgen Receptor Inhibitors, GnRH Receptor Antagonists), Disease State (Metastatic Castration-Resistant Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer), Route of Administration, Distribution Channel, and Regional Analysis for 2025 - 2032

ID: PMRREP35516

Format: PPT*, PDF, EXCEL

Last Updated: 25 Jul 2025

Industry: Healthcare

Number of Pages: 193

Persistence Market Research Report, Market Growth and Regional Outlook
Request Sample Request Customization
Buy Now

Table of Content

  1. Executive Summary
    1. Global Prostate Cancer Hormone Therapy Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2024A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Component Type
  5. Global Prostate Cancer Hormone Therapy Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
    3. Global Prostate Cancer Hormone Therapy Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Drug Class, 2019 - 2024
      3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
        1. Androgen Receptor Inhibitors
        2. Gonadotropin-Releasing Hormone (GnRH) Agonists
        3. GnRH Receptor Antagonists
        4. Anti-Androgens
        5. Combination Therapies
      4. Market Attractiveness Analysis: Drug Class
    4. Global Prostate Cancer Hormone Therapy Market Outlook: Disease State
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Disease State, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Disease State, 2025 - 2032
        1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
        2. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
        3. Hormone-Sensitive Prostate Cancer (HSPC)
      4. Market Attractiveness Analysis: Disease State
    5. Global Prostate Cancer Hormone Therapy Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 - 2032
        1. Oral
        2. Parenteral
      4. Market Attractiveness Analysis: Route of Administration
    6. Global Prostate Cancer Hormone Therapy Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
        1. Hospital Pharmacies
        2. Retail Pharmacies & Drug Stores
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
  6. Global Prostate Cancer Hormone Therapy Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
    3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Prostate Cancer Hormone Therapy Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Disease State
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Component, 2025 - 2032
      1. Androgen Receptor Inhibitors
      2. Gonadotropin-Releasing Hormone (GnRH) Agonists
      3. GnRH Receptor Antagonists
      4. Anti-Androgens
      5. Combination Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease State, 2025 - 2032
      1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      2. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
      3. Hormone-Sensitive Prostate Cancer (HSPC)
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Parenteral
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  8. Europe Prostate Cancer Hormone Therapy Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Disease State
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Androgen Receptor Inhibitors
      2. Gonadotropin-Releasing Hormone (GnRH) Agonists
      3. GnRH Receptor Antagonists
      4. Anti-Androgens
      5. Combination Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease State, 2025 - 2032
      1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      2. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
      3. Hormone-Sensitive Prostate Cancer (HSPC)
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Parenteral
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  9. East Asia Prostate Cancer Hormone Therapy Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Disease State
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Androgen Receptor Inhibitors
      2. Gonadotropin-Releasing Hormone (GnRH) Agonists
      3. GnRH Receptor Antagonists
      4. Anti-Androgens
      5. Combination Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease State, 2025 - 2032
      1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      2. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
      3. Hormone-Sensitive Prostate Cancer (HSPC)
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Parenteral
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  10. South Asia & Oceania Prostate Cancer Hormone Therapy Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Disease State
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Androgen Receptor Inhibitors
      2. Gonadotropin-Releasing Hormone (GnRH) Agonists
      3. GnRH Receptor Antagonists
      4. Anti-Androgens
      5. Combination Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease State, 2025 - 2032
      1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      2. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
      3. Hormone-Sensitive Prostate Cancer (HSPC)
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Parenteral
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  11. Latin America Prostate Cancer Hormone Therapy Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Disease State
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Androgen Receptor Inhibitors
      2. Gonadotropin-Releasing Hormone (GnRH) Agonists
      3. GnRH Receptor Antagonists
      4. Anti-Androgens
      5. Combination Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease State, 2025 - 2032
      1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      2. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
      3. Hormone-Sensitive Prostate Cancer (HSPC)
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Parenteral
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  12. Middle East & Africa Prostate Cancer Hormone Therapy Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Disease State
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Androgen Receptor Inhibitors
      2. Gonadotropin-Releasing Hormone (GnRH) Agonists
      3. GnRH Receptor Antagonists
      4. Anti-Androgens
      5. Combination Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Disease State, 2025 - 2032
      1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      2. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
      3. Hormone-Sensitive Prostate Cancer (HSPC)
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Parenteral
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Astellas Pharma Inc.
        1. Overview
        2. Segments and Components
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Pfizer Inc.
      3. Johnson & Johnson Services, Inc.
      4. Bayer AG
      5. Sanofi
      6. Myovant Sciences
      7. Tolmar Pharmaceuticals
      8. Foresee Pharmaceuticals Co., Ltd.
      9. AbbVie Inc.
      10. Endo International plc
      11. Clovis Oncology
      12. Exelixis, Inc.
      13. NantKwest (ImmunityBio)
      14. Bristol Myers Squibb
      15. Novartis AG
      16. Dr. Reddy’s Laboratories
      17. Sun Pharmaceutical Industries Ltd.
      18. Teva Pharmaceuticals
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

Thank you for taking time to visit our website, click like if you found the information on this page useful?

View All Reports
Contact Us
This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate